InvestorsHub Logo
icon url

MinnieM

06/16/20 4:57 PM

#301755 RE: JTORENCE #301752

My guess is that the volume is low due to most holding. The selling is likely from the MFO on a daily basis as evidenced from the increasing shares outstanding.

I'm ok with it since I realize the company must be raising capital for upcoming clinical trials of Brilacidin for covid. Even though I'm expecting grant money from both government and/or private funds, they have to manufacture drug in advance.

http://www.ipharminc.com/press-release/2020/4/6/innovation-pharmaceuticals-in-discussions-to-advance-brilacidin-into-human-trials-against-covid-19?rq=drug%20manufactur

the Company is investigating procurement of appropriate drug supply (i.e., manufacture of intravenous drug product),


Before covid came along, the drug being manufactured was sachets for Brilacidin OM. They need IV drug for covid trials.

This is why I'm ok with the raising of funds for upcoming clinical trials. What choice is there? They HAVE to manufacture drugs for trials. Based on conversations I've had with other shareholders it seems most have forgotten this detail.









Message in reply to:
Down again on low volume. Sure is not performing like a drug that will change the world...















icon url

Rdunn88

06/16/20 5:10 PM

#301758 RE: JTORENCE #301752

Leo’s late to the game due to no partner or financing. His only hope is the Government....